StevenRichardFeldmanMD

PubMed

• Patients' and caregivers' perspectives of the atopic dermatitis journey.
  Chan, A., Ammoury, A., Zhang, J., Tanaka, A., Shi, X., Cha, A., Tran, H., Feldman, S.> ;The Journal of Dermatological Treatment. 2024 Dec 1
• Monitoring adherence to vulvar lichen sclerosus treatment - a prospective study.
  Zaino, M., Pixley, J., Subramanian, V., Sirdeshmukh, D., Feldman, S., Pichardo, R.> ;The Journal of Dermatological Treatment. 2024 Dec 1
• Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment.
  Thyssen, J., Boeri, M., Gerber, R., Neary, M., Cha, A., Hauber, B., Cappelleri, J., Xenakis, J., Leach, C., Feldman, S., Zeichner, J.> ;The Journal of Dermatological Treatment. 2024 Dec 1
• Receptivity to misinformation is associated with a preference for complementary alternative medicine for atopic dermatitis.
  Quan Pham, Matthew L Hrin, Rima I Ghamrawi, Alan B Fleischer Jr, Sarah L Taylor, Steven R Feldman> ;International Journal of Dermatology. 2024 Apr 4
• Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients.
  Angela Lo, Hannah Y Gantz, Kamran Chodri, Greenzaid, J., Steven R Feldman, Jonathan D Greenzaid> ;Expert Opinion on Drug Metabolism & Toxicology. 2024 Apr 2
• Tapinarof cream for the topical treatment of plaque psoriasis in adults.
  Kaley Prieto, Jessica Q Duong, Steven R Feldman> ;Expert Review of Clinical Immunology. 2024 Apr 1
• Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients.
  Justin M Eichinger, Divya M Shan, Lisa Anakwenze, Steven R Feldman, Greenzaid, J., Jonathan D Greenzaid> ;Expert Opinion on Drug Metabolism & Toxicology. 2024 Mar 28
• Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review.
  Rithi J Chandy, Isabella Tan, Steven R Feldman, Aditi Chokshi> ;Journal of Cutaneous Medicine and Surgery. 2024 Mar 28
• Microbiome modulators for atopic eczema: a systematic review of experimental and investigational therapeutics.
  Lina J Chan, Brittany M Chandani, Nicholas R Kiritsis, Steven R Feldman, Greenzaid, J., Jonathan D Greenzaid> ;Expert Opinion on Investigational Drugs. 2024 Apr 1
• Live vaccinations in dermatology for immunosuppressed patients: a narrative review.
  Divya M Shan, Rithi J Chandy, Andrew Fultz, John W Sanders, Steven R Feldman> ;Archives of Dermatological Research. 2024 Mar 2
• Overview of Dermatological Manifestations Associated with the COVID-19 Infection.
  Heli Patel, Linh Tran, Steven R Feldman> ;Skin Therapy Letter. 2024 Mar 1
• Patient satisfaction surveys: who benefits?
  Shirley P Parraga, Steven R Feldman> ;International Journal of Dermatology. 2024 Apr 1
• The impact of current investigational drugs for acne on future treatment strategies.
  Patel, H., Guo, L., Feldman, S.> ;Expert Opinion on Investigational Drugs. 2024 Feb 1
• The Effect of Anchoring on Atopic Dermatitis Patients' Likeliness to Take an Injection Treatment.
  Brett R Shaffer, Mallory Zaino, Stuti Prajapati, Rithi J Chandy, Steven R Feldman> ;Journal of Cutaneous Medicine and Surgery. 2024 Feb 2
• Non-Systemic Medication for the Treatment of Prurigo Nodularis: A Systematic Review.
  Manas Ranpariya, Mallory L Zaino, Lillian E McCampbell, Tejesh Patel, Steven R Feldman> ;Journal of Cutaneous Medicine and Surgery. 2024 Jan 30
• The Fundamental Attribution Error in Dermatology.
  Raj H Patel, Jessica N Pixley, Steven R Feldman> ;Journal of Cutaneous Medicine and Surgery. 2024 Jan 28
• Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis.
  Greenzaid, J., Jonathan Greenzaid, Steven Feldman> ;Clinical Pharmacokinetics. 2024 Feb 1
• Evaluation of pentoxifylline in the treatment of necrobiosis lipoidica: outcomes in 10 patients.
  Hrin, M., Oscherwitz, M., Jorizzo, J., Feldman, S., Huang, W.> ;International Journal of Dermatology. 2024 Mar 1
• Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
  Park, Y., Kay, J., Cross, R., Feldman, S., Hanauer, S.> ;Advances in Therapy. 2024 Feb 1
• Dupilumab for moderate-severe atopic dermatitis: a real-world, single-center retrospective study of 122 patients in the United States.
  Veronica K Emmerich, Josiah A Williams, Matthew L Hrin, Steven R Feldman, Lindsay C Strowd> ;International Journal of Dermatology. 2024 Apr 1
• Understanding the Medical Dictionary for Regulatory Activities (MedDRA) reporting of herpes simplex virus (HSV) adverse events in atopic dermatitis clinical trials.
  Rachel E Tao, Jessica N Pixley, Christina L Kontzias, Steven R Feldman> ;Archives of Dermatological Research. 2023 Dec 12
• Navigating Challenges and Advances in Pediatric Psoriasis and Atopic Dermatitis Treatment.
  Lovell, K., Strowd, L., Feldman, S.> ;Children. 2023 Dec 11
• Could red and near-infrared emitting fabric technology improve the severity of psoriasis, polymorphous light eruption, and alopecia areata?
  Jessica N Pixley, Rithi J Chandy, Irma Richardson, Joseph L Jorizzo, Steven R Feldman> ;The Journal of Dermatological Treatment. 2023 Dec 1
• 5 citations
  Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis.
  Rachel C Ruda, Katherine A Kelly, Steven R Feldman> ;The Journal of Dermatological Treatment. 2023 Dec 1
• 1 citations
  Drug tolerability versus drug safety.
  Rachel Tao, Steven R Feldman, Stuti Prajapati> ;The Journal of Dermatological Treatment. 2023 Dec 1
• Join now to see all

Journal Articles

• Heterogeneity and Variation of Innovator Biologics  
  Dev R Sahni, Steven R Feldman, Journal of The European Academy of Dermatology and Venereology
• Effectiveness of the Tacrolimus Swish-and-Spit Treatment Regimen in Patients with Geographic Tongue  
  Joseph L Jorizzo, Steven R Feldman, JAMA
• Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families  
  Jonathan I Silverberg, Amy S Paller, Mark Boguniewicz, Sarah L Chamlin, Eric L Simpson, Lawrence F Eichenfield, Steven R Feldman, Dermatology and Therapy
• Association of Inadequately Controlled Disease and Disease Severity with Patient-Reported Disease Burden in Adults with Atopic Dermatitis  
  David J Margolis, Tissa Hata, Steven R Feldman, JAMA
• Minimal Clinically Important Difference (MCID) for Work Productivity and Activity Impairment (WPAI) Questionnaire in Psoriasis Patients  
  J J Wu, S R Feldman, O Goldblum, Journal of The European Academy of Dermatology and Venereology
• Online Reviews of Physicians, Valuable Feedback, Valuable Advertising  
  Hill D, Feldman SR, JAMA Dermatology, 1/1/2016
• Overview: Secukinumab for Psoriasis  
  Culp L, Farhangian ME, Feldman SR, The Dermatologist, 1/1/2016
• Ethical consideration in adherence research  
  Patel NU, Moore BA, Craver RF, Feldman SR, Patient Prefer Adherence, 1/1/2016
• A boxed warning for inadedquate psoriasis treatment  
  Kagha KC, Blauvelt A, Anderson KL, Leonardi CL, Feldman SR, Cutis, 1/1/2016
• Tofacitnib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque p...  
  Feldman Sr, Thaci D, Gooderham M, Augustin M, de la Cruz C, Mallbris L, Buonanno M, Tatulych S, Kaur M, Lan S, Valdez H, Mamolo C, J Am Acad Dermatol, 1/1/2016
• Cardiovascular Disease Outcomes Associated with Three Major Inflammatory dermatologic diseases: A propensity-matched case control study  
  Marshall VD, Moustafa F, Hawkins SD, Balkrishnan R, Feldman SR, Dermatol Ther, 1/1/2016
• Current status and future prospects for bioloic treatments of psoriasis  
  Cline A, Hill D, Lewallen R, Feldman SR, Expert Rev Clin Immunol, 1/1/2016
• Review of maintenance of rsponse to psoriasis treatments  
  Bartos S, Hill D, Feldman SR, J Dermatolog Treat, 1/1/2016
• Review of patient registries in dermatology  
  DiMarco G, Hill D, Feldman SR, J Am Acad Dermatol, 1/1/2016
• Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis  
  Kin KC, Hill D, Feldman SR, Expert Rev Clin Pharmacol, 1/1/2016
• New developments in the treatment of rosacea - role of once-daily ivermectin cream  
  Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR, Clin Cosmet Investig Dermatol, 1/1/2016
• The cost of applying to dermatology residency  
  Huang WW, Feldman SR, J Am Acad Dermatol, 1/1/2016
• Advances in and hope for the treatment of parasitosis  
  Feldman SR, Feldman SR, 1/1/2016
• Costs of Common Psoriasis Medications, 2010-2014  
  James SM, Hill DE, Feldman SR, J Drugs Dermatol, 1/1/2016
• Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: long-term efficacy and safety results from 2 randomized phase-III studies a...  
  Papp KA, Krueger JG, Feldman SR. Langley RG, Thaci D, Torii H, Tyring S, Wolk R, Gardner A, Mebus C, Tan H, Luo Y, Gupta P, Mallbris L, Tatulych S, J Am Acad Dermatol, 1/1/2016
• Rosacea patients seeking advice: Qualitative analysis of patients' posts on a rosacea support forum  
  Alinia H, Moradi Tuchayi S, Farhangian ME, Huang KE, Taylor SL, Kuo S, Richardson I, Feldman SR, Dermatolog Treat, 1/1/2016
• A Review of Localized Office and Hope Devices in the Treatment of Psoriasis  
  Buckland M, Smith JS, Hill D, Feldman SR, Journal of Psoriasis and Psoriatic Arthritis, 1/1/2016
• Prevalence of Rosacea in Community Settings  
  Moustafa F, Hopkinson D, Huang KE, Feldman S, J Cutan Med Surg, 1/11/2015
• Reply to Letter: Primary Nonadherence in Acne Treatment: The Importance of Cost Consciousness  
  Feldman SR, Anderson K, JAMA Dermatol, 1/1/2015
• New Frontiers in Psoriasis Treatment  
  Feldman SR, Journal of Drugs in Dermatology, 1/1/2015
• Join now to see all

Books/Book Chapters

• Practical Psoriasis Management 
  Feldman SR, Farhangian ME, Anderson KLCreateSpace Independent Publishing Platform2015
• An Illustrated Dictionary of Behavioral Economics for Healthcare Professionals 
  Davis SA, Feldman SRCreateSpace Independent Publishing Platform2014
• Dermatopathology Primer of Inflammatory Diseases 
  SR Feldman, OP Sangueza, R. Pichardo-Geisinger, MA Kinney, A. Feneran, S. NarahariMedical Quality Enhancement Corporation, Winston-Salem, NC2012
• Current & Emerging Treatments for Psoriasis - e-Book 
  Feldman SRFuture Medicine Ltd.2011
• Evidence Based Dermatology 
  Chapter: Cost-effectiveness of Roseca Treatments 
  Page 1056 - 1062Iaconi A, Wu CH, Rayhan DJ, Yentzer B, Feldman SR, Balkrishnan REditors: Maibach H, Gorouhi F.People's Medical Publishing HouseEdition 2nd,2011
• Evidence Based Dermatology 
  Chapter: Adherence to Treatment 
  Page 1073 - 1080Levender MM, Balkrishnan R, Feldman SREditors: Maibach H, Gorouhi F.People's Medical Publishing HouseEdition 2nd,2011
• Evidence Based Dermatology 
  Chapter: Treatment of Psoriasis 
  Page 213 - 234Pugashetti R, De Luca J, Feldman SREditors: Maibach H, Gorouhi F.People's Medical Publishing HouseEdition 2nd,2011
• The Psoriasis and Psoriatic Arthritis Pocket Guide: Treatment Algorithms and Management Options 
  Van Voorhees A. Feldman SR, Koo JYM, Lebwohl M, Menter ANational Psoriasis Foundation, Portland, OR2010
• Compartments: How the Brightest, Best Trained, and Most Caring People can make Judgments That are Completely & Utterly Wrong 
  Feldman SRXlibris Corporation2009
• Practical Ways To Improve Patients' Treatment Outcomes 
  Feldman SRMedical Quality Enhancement Corporation, Winston-Salem, NC2009
• Conn's Current Therapy 
  Chapter: Acne Vulgaris and Rosacea 
  Page 773 - 776Feldman SR, Fleischer AB JrEditors: Rakel RE, Bope ET.Saunders, an imprint of Elsevier, Inc., Philadelphia, PA2008
• Wiley StatsRef: Statistics Reference Online 
  Chapter: Dermatology Trials 
  Feldman, SR and Clark, AR2008
• Wiley Encyclopedia of Clinical Trials 
  Chapter: Dermatology Trials 
  Feldman, SR and Clark, ARJohn Wiley & Sons, Inc.2007
• Mild-to-Moderate Psoriasis 
  Chapter: General Approach to Psoriasis Treatment 
  Page 3 - 7Feldman SREditors: Koo JYM, Lebwohl MG, Lee CS.Informa Healthcare USA, Inc., New York, NY2006
• Mild-to-Moderate Psoriasis 
  Chapter: Topical Corticosteroids 
  Page 41 - 58Givan J, Pearce D, Feldman SREditors: Koo JYM, Lebwohl MG, Lee CS.Informa Healthcare USA, Inc., New York, NY2006
• Phototherapy Treatment Protocols: For Psoriasis and Other Phototherapy Responsive Dermatoses 
  Zanolli MD, Feldman SRTaylor & Francis, Abingdon, EnglandEdition 2nd,2005
• The Psoriasis and Psoriatic Arthritis Pocket Guide: Treatment Algorithms and Management Options 
  Feldman SR, Koo JYM, Lebwohl MG, Menter A, Van Voorhees ANational Psoriasis Foundation, Portland, OREdition 2nd,2005
• Handbook of Dermatologic Drug Therapy 
  Feldman SR, Phelps KC, Verzino KCInforma Healthcare2005
• Psoriasis and Psoriatic Arthritis: An Integrated Approach 
  Chapter: Disability and Quality of Life Considerations in Psoriasis 
  Page 109 - 117Feldman SR, Rapp SREditors: Gordon KB, Ruderman E.Springer Verlag, Berlin, Germany2005
• Therapy of Moderate-to-Severe Psoriasis 
  Chapter: The Art and Practice of UVB Phototherapy for Treatment of Psoriasis 
  Koo J, Bandow G, Feldman SREditors: Weinstein GD, Gottlieb AB.Marcel Dekker, New York, NYEdition 2nd,2003
• Dermatological Signs of Internal Disease 
  Chapter: Adrenal, Androgen-Related and Pituitary Disorders. 
  Page 187 - 191Feldman SR, Jorizzo JLEditors: Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ.Elsevier Science Limited, Philadelphia, PAEdition 3rd,2003
• Emergency Dermatology: A Rapid Treatment Guide 
  Fleischer AB, Feldman SR, McConnell CF, Petrazzuoli M, Pardasani A, Hess MRMcGraw-Hill Professional, New York, NY2002
• CRC Directory of Outpatient Prescribed Medications: Demographics Data Analysis 2003/2004 
  Fleischer AB, Jr, Teuschler H, Chen GJ, Feldman SRCRC Press-Parthenon Publishers2002
• Psoriasis: Treatment Options and Patient Management 
  Lebwohl MG, Feldman SR, Koo JYM, Menter MANational Psoriasis Foundation, Portland, OR2002
• Dermafax 
  Feldman SR, Verzino KC, Phelps KCBlackwell Science, Malden, MA2001
• Join now to see all

Abstracts/Posters

• Differences in patient satisfaction with primary care and specialty care.
  Feldman SR, International Society for Pharmacoeconomics and Outcomes Research Meeting, Baltimore, MD, 1/24/2011
• Medication choice and associated health care outcomes and costs for patients with acne and acne related conditions in the United States.
  Feldman SR, International Society for Pharmacoeconomics and Outcomes Research Meeting, Baltimore, MD, 1/23/2011
• Medication adherence to topical medications and healthcare expenditures in Medicaid-enrolled child with atopic dermatitis.
  Feldman SR, International Society for Pharmacoeconomics and Outcomes Research Meeting, Baltimore, MD, 1/23/2011
• Double-blind, randomized, bilateral comparison of topical 6% salicylic acid cream and 20% alpha/poly hydroxyl acid cream to reduce scaling of lesions associated with m...
  Feldman SR, American Academy of Dermatology Meeting, Miami, FL, 1/7/2010
• Cost effectiveness of Imiquimod in superficial basal cell carcinoma treatment.
  Feldman SR, ISPOR 2nd Latin American Conference, Rio de Janeiro, Brazil, 1/11/2009
• Prescription refills and health care costs associated with topical metronidazole in Medicaid enrolled patients with rosacea.
  Feldman SR, ISPOR 11th Annual European Congress, Athens, Greece, 1/8/2008
• The Relationship Between Physician Empathy and Satisfaction With Primary Care Physicians: Findings From an Internet Based Survey.
  Feldman SR, International Society for Pharmacoeconomics and Outcomes Research Meeting, Dublin, Ireland, 1/20/2007
• Prior Authorization for Topical Psoriasis Treatments: Is it Cost-Beneficial for Managed Care?
  Feldman SR, International Society for Pharmacoeconomics and Outcomes Research Meeting, Dublin, Ireland, 1/20/2007
• Correlates of Patient Satisfaction with physician Visit: Differences Between Elderly and Non-Ederly Survey Respondents.
  Feldman SR, International Society for Pharmacoeconomics and Outcomes Research Meeting, Dublin, Ireland, 1/20/2007
• Acne-Quality of Life Inventory (Ance-QOLI): Development and Validation
  Rapp SR, Feldman SR, Graham GF, Fleischer AB, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Neuroticism, Acne Severity, and Quality of Life
  Feldman SR, Fleischer AB Jr, Rapp DA, Rapp SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Social Sensitivity Associated with Greater Negative Impact of Acne
  Feldman SR, Fleischer AB Jr, Rapp D, Rapp SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• A randomized double-blind controlled study to evaluate time to recurrence of hand dermatitis in patients treated with a prednisone taper combined with topical tacrolim...
  Feldman SR, Krejci-Manwaring J, McCarty MA, Fleischer AB Jr, Jorizzo JL, Hartle JE, Johnson K, Willard J, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Dermatologists interpret a large percentage of dermatopathology specimens.
  Hancox JG, Neville JA, Chen J, Coldiron B, Williford PM, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• A comparison of dermatopathology training of dermatology and pathology residents in the US.
  Singh S, Grummer SE, Hancox JG, Sangueza OP, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Use of a Consultation/Prescription Form to Improve Communication with Referring Doctors.
  Guest CB, Khanna V, Hawes D, Baum N, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Alopecia Areata in the United States: Outpatient Utilization and Common Prescribing Patterns
  McMichael AJ, Pearce DJ, Wasserman D, Camacho FT, Fleischer Ab Jr, Feldman SR, Balkrishnan R, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Estimating Cost of Treatment Episode of non-Melanoma Skin Cancer in Elderly
  Chen GJ, Yelverton CB, Housman TS, Williford PM, Teuschler HV, Fleischer AB Jr, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Indoor Tanning UV exposure relieves a patient's back pain in a controlled trial.
  Kaur M, Feldman SR, Rapp SR, Fleischer AB Jr, Lang W, Liguori A, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Naltrexone Toxicity in Frequent Tanners
  Kaur M, Liguori A, Feldman Sr, Fleischer AB Jr., American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Acitretin in Combination with Home Broadband Ultraviolet Light as a Psoriasis Treatment
  Pearce DJ, Yelverton C, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Death from Psoriasis: Representative U.S. Data
  Chen GH, Lucas J, Pearce D, Balkrishnan R, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• How much for one unit of DLQI improvement? A cost-effectiveness analysis of biologics in psoriasis.
  Nelson A, Pearce DJ, Fleischer AB Jr, Balkrishnan R, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Low-dose (25 mg) acitretin in the treatment of psoriasis.
  Yaroshinsky A, Roweel R, Krochmal L, Pearce DJ, Murad E, Ziel K, Klinger S, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Medication and Health Care Service Utilization Related to Depressive Symptoms in Older Adults with Psoriasis
  Kulkarni AS, Balkrishnan R, Camacho F, Anderson RT, Feldman SR, American Academy of Dermatology Meeting, New Orleans, LA, 1/18/2005
• Join now to see all

Other

• Manipulating Mindsets to Improve Patient Outcomes: Is It Ethical? Can It Be Avoided? 
  Steven Feldman, MD, Journal of The European Academy of Dermatology and Venereology
  https://www.doximity.com/articles/e5054e1a-38cf-444b-992a-c9455a02c0be
  UpToDate, Wolters Kluwer Health - 2013-03-28
• Rapid, Successful Treatment of Atopic Dermatitis Recalcitrant to Topical Corticosteroids 
  Steven Feldman, MD, Pediatric Dermatology
  https://www.doximity.com/articles/c7a81c02-09de-484c-8dd2-d96e32cc154f
  UpToDate, Wolters Kluwer Health - 2012-11-15
• Reflections on Modern Dermatology. 
  Feldman SR, The Dermatologist
  1/1/2017
• Understanding the Cost of Dermatologic Care: A Survey Study. 
  Feldman SR, PracticeUpdate.com
  http://www.practiceupdate.com/content/understanding-the-cost-of-dermatologic-care-a-survey-study/49839/65/4/1
  1/1/2017
• Cost of Diagnosing Psoriasis and Rosacea for Dermatologists Versus Primary Care Physicians. 
  Feldman SR, PracticeUpdate.com
  http://www.practiceupdate.com/content/equivalent-cost-of-diagnosing-psoriasis-and-rosacea-by-dermatologists-and-primary-care-physicians/50438/65/4/1
  1/1/2017
• Assessing Performance. 
  Feldman SR, The Dermatologist
  1/1/2017
• Evaluation of Adherence Predictors for the Treatment of Moderate to Severe Psoriasis With Biologics: The Importance of Physician-Patient Interaction and Communication. 
  Feldman S, PracticeUpdate.com
  http://www.practiceupdate.com/content/physician-patient-interaction-and-communication-impact-adherence-to-biologic-treatment-in-patients-with-psoriasis/52058/65/4/1
  1/1/2017
• Navigating the Turbulent Health Care System. 
  Feldman SR, The Dermatologist
  1/1/2017
• Framing Adherence. 
  Feldman SR, PM360online.com
  https://www.pm360online.com/framing-adherence
  1/15/2016
• Risk of Multiple Sclerosis in Patient with Psoriasis. 
  Feldman SR, PracticeUpdate.com
  http://www.practiceupdate.com/c/32588/1/4
  1/1/2016
• So You're Saying There's a Chance.... 
  Feldman SR, PM360online
  https://www.pm360online.com/so-youre-saying-theres-a-chance
  1/1/2016
• Letting go of emotional affiliations for the greater good. 
  Feldman SR, The Dermatologist
  1/1/2016
• Commitment to our patients' well-being. 
  Feldman SR, The Dermatologist
  1/1/2016
• Apremilast, an Oral Phosphodiesterase-4 Inhibitor, in the Treatment of Palmoplantar Psoriasis: Results of a Pooled Analysis From Phase II PSOR-005 and Phase III Effica... 
  Feldman SR, PracticeUpdate.com
  1/1/2016
• ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A Retrospective Observational Study on Biologic Drug Survival in Daily Practice. 
  Feldman SR, PracticeUpdate.com
  http://www.practiceupdate.com/content/orbit-outcome-and-retention-rate-of-biologic-treatments-for-psoriasis-a-retrospective-bservational-study-on-biologic-drug-survival-in-daily-practice/37837/65/4/1
  1/1/2016
• Volunteerism can be life-affirming. 
  Feldman SR, The Dermatologist
  1/1/2016
• The Powerful Tool of Inertia. 
  Feldman SR, The Dermatologist
  1/1/2016
• Phase 3 Trials of lxekizumab in Moderate-to-Severe Plaque Psoriasis. 
  Feldman SR, PracticeUpdate.com
  http://www.practiceupdate.com/content/ixekizumab-in-moderate-to-severe-plaque-psoriasis/40425/65/4/1
  1/1/2016
• Automating Empathy. 
  Feldman SR, The Dermatologist
  1/1/2016
• First Impressions and Interactions Matter. 
  Feldman SR, The Dermatologist
  1/1/2016
• Medical Costs and Responsible Stewardship. 
  Feldman SR, The Dermatologist (in Special Issue: Psoriasis Treatment Today)
  1/1/2016
• Election Season is Upon Us. 
  Feldman SR, The Dermatologist
  1/1/2016
• Beware of Selection Bias. 
  Feldman SR, The Dermatologist
  1/1/2016
• What Routine lab monitoring is needed for biologics? 
  Feldman SR, The Dermatologist
  1/1/2016
• An Enormous Wasted Opportunity - Packaging. 
  Feldman SR, PM360 Magazine
  1/1/2016
• Join now to see all